Back
Ovid Therapeutics Stock Price Chart
Sponsored
OVID
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
OVID
Ovid Therapeutics
Last Price:
1.16
Seasonality Move:
-0.74%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and OVID is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ovid Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.13 | Buy |
20-day SMA: | 1.15 | Buy |
50-day SMA: | 1.06 | Buy |
200-day SMA: | 2.51 | Sell |
8-day EMA: | 1.13 | Buy |
20-day EMA: | 1.12 | Buy |
50-day EMA: | 1.22 | Sell |
200-day EMA: | 2.16 | Sell |
Ovid Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.54 | Buy |
Chaikin Money Flow: | 92348 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.08 - 1.22) | Buy |
Bollinger Bands (100): | (0.7 - 2.72) | Sell |
Ovid Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ovid Therapeutics Stock
Is Ovid Therapeutics Stock a Buy?
- Ovid Therapeutics share price is 1.17 while OVID 8-day simple moving average is 1.13, which is a Buy signal.
- The stock price of OVID is 1.17 while Ovid Therapeutics 20-day SMA is 1.15, which makes it a Buy.
- Ovid Therapeutics 50-day simple moving average is 1.06 while OVID share price is 1.17, making it a Buy technically.
- OVID stock price is 1.17 and Ovid Therapeutics 200-day simple moving average is 2.51, creating a Sell signal.
OVID Technical Analysis vs Fundamental Analysis
Sell
16
Ovid Therapeutics (OVID)
is a Sell
Is Ovid Therapeutics a Buy or a Sell?
-
Ovid Therapeutics stock is rated a Sell
The current Ovid Therapeutics [OVID] share price is $1.17. The Score for OVID is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Ovid Therapeutics Stock Info
Market Cap:
83.04M
Price in USD:
1.17
Share Volume:
92.35K
Ovid Therapeutics 52-Week Range
52-Week High:
4.10
52-Week Low:
0.68
Sell
16
Ovid Therapeutics (OVID)
is a Sell
Ovid Therapeutics Share Price Forecast
-
What is the Ovid Therapeutics stock price today?
The Ovid Therapeutics stock price is 1.17 USD today. -
Will OVID stock go up or go down?
Ovid Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Ovid Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ovid Therapeutics is overvalued.
Is Ovid Therapeutics Stock a Buy?
- Ovid Therapeutics share price is 1.17 while OVID 8-day exponential moving average is 1.13, which is a Buy signal.
- The stock price of OVID is 1.17 while Ovid Therapeutics 20-day EMA is 1.12, which makes it a Buy.
- Ovid Therapeutics 50-day exponential moving average is 1.22 while OVID share price is 1.17, making it a Sell technically.
- OVID stock price is 1.17 and Ovid Therapeutics 200-day simple moving average is 2.16, creating a Sell signal.
Fundamental Analysis of Ovid Therapeutics
Is Ovid Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.23 per share.
Technical Analysis of Ovid Therapeutics
Should I short Ovid Therapeutics stock?
- OVID Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Ovid Therapeutics is a Buy
- Ovid Therapeutics Relative Strength Index (RSI) is 53.54, which suggest Ovid Therapeutics is overbought
- The Bollinger Bands (25) for Ovid Therapeutics is (1.08 - 1.22), which suggest Ovid Therapeutics is a Sell
- The Bollinger Bands (100) for Ovid Therapeutics is (0.7 - 2.72), which suggest Ovid Therapeutics is a Sell
* Ovid Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.